Heliox and Adjunct Therapies, explained for the bedside and the exam

What the concept actually says

Heliox is a blend of helium and oxygen, typically in ratios such as 80:20 or 70:30 helium to oxygen, delivered by mask or through a ventilator circuit. Helium is far less dense than nitrogen, the gas it displaces from room air, so the resulting mixture flows more readily through a narrowed passage, particularly where flow is turbulent rather than smooth.

In practice this means heliox is reached for in upper airway obstruction: severe croup, post-extubation stridor, angioedema affecting the airway, or an airway narrowed by tumour or vocal cord dysfunction. It reduces the work of breathing and the audible stridor almost immediately when it helps, which is itself diagnostic information about where the obstruction sits.

The oxygen fraction available is limited by the need to keep enough helium in the mix for the density benefit to hold, so heliox is not suitable for a patient who needs a high FiO2. It is a bridge, not a therapy that resolves the obstruction on its own.

The clinical reasoning behind it

Airflow through a narrowed tube becomes turbulent, and turbulent flow resistance depends heavily on gas density; laminar flow depends more on viscosity, where helium offers less advantage. This is why heliox helps most in obstruction near the larynx and trachea, where flow is genuinely turbulent, and offers little benefit in lower airway disease like bronchospasm from asthma, where resistance is dominated by different mechanics.

The core principle the whole therapy rests on is that heliox buys time. It lowers the work of breathing and can prevent exhaustion and respiratory arrest while the actual cause, whether that is oedema from croup, an allergic reaction, or a structural lesion, is treated with steroids, epinephrine, or surgical intervention, or while preparations are made for definitive airway control. It never fixes the obstruction itself and is not a substitute for intubation, tracheostomy, or another secured airway if the patient continues to deteriorate.

Applying it under time pressure

At the bedside, heliox is used as a stabilising measure while the team simultaneously prepares for the possibility that the airway will need to be secured surgically or with an endotracheal tube. Starting heliox should never delay calling for anaesthesia or ENT support in a patient with worsening stridor; it runs in parallel with escalation, not instead of it.

Watch the patient's work of breathing and stridor continuously rather than relying on oxygen saturation alone, since saturation can remain normal on supplemental oxygen even as the patient tires and the airway narrows further. A patient who stops improving on heliox, or whose stridor worsens despite it, needs immediate escalation. Document the ratio and flow rate delivered, since switching cylinders or misreading the blend can silently reduce the density benefit.

Common misconceptions

The most common misconception is treating heliox as a treatment for the underlying condition rather than a temporising measure; a student who orders it and then relaxes their monitoring has misunderstood its role entirely. Continuous reassessment matters more with heliox running than without it, because clinical improvement can mask ongoing progression of the obstruction underneath.

A second misconception is applying it broadly to any patient in respiratory distress. Heliox does little for lower airway or parenchymal disease, so using it for a patient with pneumonia or an asthma exacerbation without upper airway involvement is unlikely to help and may delay recognition that a different intervention is needed. A third is forgetting the oxygen limitation: a hypoxic patient who needs a high FiO2 is often not a good heliox candidate, since the mixture cannot deliver both a high oxygen concentration and a strong density benefit at once.

Practice scenarios

A toddler with severe croup has inspiratory stridor at rest, retractions, and is tiring despite nebulised epinephrine and dexamethasone. Heliox is started to reduce work of breathing while the team monitors closely for signs that intubation will be needed regardless; the correct nursing action is continuous reassessment, not relief that the stridor has quietened.

An adult is extubated after prolonged intubation and develops stridor within the hour. Heliox may be trialled while racemic epinephrine and steroids are given, but the team stays at the bedside with reintubation equipment ready, because heliox buying time is not the same as the obstruction resolving.

A patient with an asthma exacerbation and audible wheeze, not stridor, is a poor candidate for heliox; the obstruction here is in smaller lower airways where bronchodilators and steroids are the primary intervention.

Key takeaways

Heliox works because helium's lower density improves turbulent gas flow through a narrowed upper airway, easing the work of breathing. It is indicated for upper airway obstruction such as severe croup, post-extubation stridor, and similar presentations, and offers little in lower airway disease.

It buys time. It does not treat the cause of the obstruction and does not replace intubation, tracheostomy, or another definitive airway when the patient's condition demands one. Continuous monitoring during heliox therapy, and readiness to escalate immediately if it stops working, is the nursing responsibility that makes the therapy safe rather than falsely reassuring.